According to the invention there is provided the use of melagatran, or a pharmaceutically-acceptable derivative thereof, for the manufacture of a medicament for the treatment of Type I diabetes.KORSGREN OLLENILSSON BO
Genome-Wide Scan for Linkage to Type 1 Diabetes in 2,496 Multiplex Families From the Type 1 Diabetes Genetics Consortium OBJECTIVEType 1 diabetes arises from the actions of multiple genetic and environmental risk factors. Considerable success at identifying common genetic var... P Concannon,WM Chen...
Intensive Polypharmacological Treatment of Type 2-diabetes in Daily Clinical Practice Type 2-diabetes is a disease in growth associated with both personal and societal costs. App. 2 % of the population has diagnosed type 2-diabetes, and for the 60 year olds the prevalence of the diagnosis is ...
Cognition in the early stage of type 2 diabetes. Diabetes Care. 2009;32(7):1261-5.12. Cooray GK, Hyllienmark L, Bris mar T. Decreased cortical connec tivity and information flow in type 1 diab... TUK Påverka,RF Demens 被引量: 0发表: 0年 FW: Web of Knowledge Alert - ...
BROQUA, PIERRESUDRE, BEATRICEAUBERT, MICHEL L
Fedme og type 2-diabetes: behandlingsmæssige fiaskoeriodomethanepromotercarbon dioxidemethanolmetal methoxidedimethylcarbonateStudies of the binding of NADPH and ADP to L-glutamate dehydrogenase by ...
Human glukagonlignende peptid-1 etterligner og deres anvendelse i behandling av diabetes og relaterte tilstander.The present invention provides novel human glucagon-like peptide-1 (GLP-1) peptide mimics that mimic the biological activity of the native GLP-1 peptide and thus are useful for ...
Benzoic acid derivatives of formula (I), which act as peroxisome proliferator activated receptor (PPAR) agonists, in particular states of insulin resistance including type 2 gamma receptors (PPAR), and so are useful therapeutically in the treatment of diabetes mellitus. In said formula Q, X, Y ...
2?OCH3 or CF3; a process for the preparation of such compounds, a pharmaceutical composition containing such compounds and the use of such compounds and compositions in medicine.RAMI, HARSHAD KANTILALHAIGH, DAVID
The use of ketoconazole or molecules resembling ketoconazole but with some side-chains, not affecting the biological activity compared to ketoconazole, changed, for the manufacture of drugs for medical treatment of diabetes mellitus type II as well as for counteracting the other risk factors being ...